American Century Companies Inc. Boosts Bio-Techne Stake

Investment firm increases holding in biotech company by 78.3% in third quarter

Mar. 3, 2026 at 2:31am

Got story updates? Submit your updates here. ›

American Century Companies Inc. has significantly increased its stake in Bio-Techne Corp, a biotechnology company, according to a recent 13F filing with the SEC. The investment firm boosted its position in Bio-Techne by 78.3% during the third quarter, now owning approximately 2 million shares worth over $113 million.

Why it matters

The substantial increase in American Century's position in Bio-Techne suggests the investment firm sees strong growth potential in the biotech company. This could signal positive sentiment around Bio-Techne's business and future prospects among institutional investors.

The details

According to the 13F filing, American Century Companies Inc. added 894,987 shares of Bio-Techne during the third quarter, bringing its total position to 2,037,806 shares. This represents approximately 1.31% ownership of the biotechnology company.

  • The increase in American Century's stake occurred during the third quarter of the year.

The players

American Century Companies Inc.

An investment management firm that oversees over $200 billion in assets.

Bio-Techne Corp

A biotechnology company that develops, manufactures, and sells high-quality reagents, instruments, and services for the research, diagnostic, and bioprocessing markets.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in American Century's position in Bio-Techne suggests the investment firm sees strong growth potential in the biotech company, which could signal positive sentiment around Bio-Techne's business and future prospects among institutional investors.